|Bid||6.39 x 1100|
|Ask||6.55 x 1000|
|Day's Range||5.99 - 6.63|
|52 Week Range||3.15 - 15.85|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 16, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||8.30|
Casper Sleep (NYSE: CSPR), Root (NASDAQ: ROOT), and BlueCity Holdings (NASDAQ: BLCT) are all trading lower than their IPO price tags, but they may not stay broken for long if positive catalysts play out in the year ahead. Let's see why Casper Sleep, Root, and BlueCity can get it right the second time around. Casper Sleep was initially hoping to price its IPO between $17 and $19, but underwriters were only able to take it public at $12.
It could be a bleak holiday season for Macy's, Wall Street warns.
Shares of Sleep Number Corp. rallied 2.7% into record territory in afternoon trading Tuesday, after BofA Securities analyst Curtis Nagle upgraded the mattress maker, saying he was now "more positive" on forward earnings growth after several solid quarterly reports and continued industry strength. At the same time, Nagle turned bearish on Casper Sleep Inc. , citing disappointing third-quarter results and continued sales underperformance relative to its peers. But Casper's stock erased an earlier loss of as much as 6.7% to trade up 0.2%. For Sleep Number, Nagle raised his stock price target by 66% to $73: "Very simply, our prior view on earnings growth was too punitive in factoring potential long-term risks that at least for now are not playing out," Nagle wrote in a note to clients. For Casper, Nagle cut is rating to underperform from neutral, and slashed his target by 45% to $5.50. "If not high growth now, then when," Nagle wrote. "The fact that the company is losing market share [to] peers in the strongest bedding market ever is a concern." Over the past three months, Sleep Number's stock has rallied 53.1% while Casper shares have shed 22.9% and the S&P 500 has gained 7.0%.